goto UNSW  home page  
Contacts Library myUNSW WebCT
 Therapeutic Basis of Drug Use and Development 1 - PHPH9108
PRINT THIS PAGE
 The Red Centre promenade
   
   
   
 
Campus: Kensington Campus
 
 
Career: Postgraduate
 
 
Units of Credit: 6
 
 
EFTSL: 0.125 (more info)
 
 
Contact Hours per Week: 0
 
 
Fee Band: 2 (more info)
 
 
Further Information: See Class Timetable
 
  

Description

This course aims to provide an understanding of the medical problems and treatments that need to be understood in developing new therapeutic agents and optimizing their use. Emphasis will be on highlighting the strengths and weaknesses of present therapies and identification of current research aimed at developing new therapeutic agents. The course begins with a review of drug safety including mechanism of adverse drug reactions and drug interactions, together with the influence of age, race and disease states on the tendency to develop adverse responses to medication. The course provides and integrated description of relevant physiology, pathophysiology, disease states: (a) infectious disease: bacterial, fungal, viral and parasitic infections: (b) immunological disorders: immunodefiency, hypersensitivity, transplantation: (c) haemotology: anaemias, haemorrhagic disorders, disorders of white blood cells, leukaemias, lymphomas; (d) cardiovascular disorders: cardiac arrhythmia, ischaemic heart disease, heart failure, hypertension, vascular disorders; (e) respiratory tract disorders: upper respiratory tract disorders, asthma, chronic obstructive pulmonary disease, acute bronchitis, bronchiectasis, cystic fibrosis, pneumonia; (f) renal tract disorders: renal failure, disorders of renal tubule function, obstructive uropathies, myoneurogenic disorders, incontinence, neoplasms: (g) ) gastrointestinal disorders: oesophageal disorders, gastritis, peptic ulcer, diarrhoea and constipation, gastroenteritis, malabsorption syndromes, chronic inflammation of the bowel, gastrointestinal neoplasms; (h) hepatic and biliary disorders: jaundice, ascites, fibrosis, cirrhosis, hepatitis, neoplasms.

Note: The course is elective for programmes 5504, and 9060.

URL for this page:

© The University of New South Wales (CRICOS Provider No.: 00098G), 2004-2011. The information contained in this Handbook is indicative only. While every effort is made to keep this information up-to-date, the University reserves the right to discontinue or vary arrangements, programs and courses at any time without notice and at its discretion. While the University will try to avoid or minimise any inconvenience, changes may also be made to programs, courses and staff after enrolment. The University may also set limits on the number of students in a course.